EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic Studies of Arene–Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs

Paweł Hikisz, Ewelina Namiecińska iD, Piotr Paneth iD, Elzbieta Budzisz iD

Molecules · 2023

DOI: 10.3390/molecules28093969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Paweł Hikisz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ruthenium, Coordination Complexes, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arene–ruthenium(II) complexes with carbothioamidopyrazoles at the C-2 and C-5 positions have been recognized as chemotherapeutic agent alternatives to cisplatin and its oxaliplatin analogs. The aim of this study was to continue research on the biological aspect of arene–ruthenium(II) complexes and their anticancer activity. The present paper includes an additional 12 new tumor cells, analyzed by MTT, and employs a series of extended bioassays to better understand their potential mechanism of antitumor activity. The following tests were conducted: membrane permeability studies, intramolecular reactive oxygen and nitrogen species (ROS/RNS) assays, mitochondrial potential changes, DNA analysis by comet assay using the electrophoresis method, measurement of cleaved PARP protein levels, and determination of apoptotic and necrotic cell fractions by fluorescence microscopy. Additionally, the article presents lipophilicity studies based on RP-TLC and molecular docking studies. We hope that the presented data will prove useful in practical treatment, especially for patients with cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsRutheniumCoordination ComplexesNeoplasmsHumansCell Line, TumorMolecular Docking SimulationCisplatinReactive Oxygen SpeciesDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

anticancer activityarene–ruthenium(II) complexescarbothioamidopyrazolesmolecular docking

Substanzen

Antineoplastic AgentsRutheniumCisplatinReactive Oxygen SpeciesCoordination Complexes

Autor:innen und Institutionen

  • Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
  • Department of the Chemistry of Cosmetic Raw Materials, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.
  • Institute of Applied Radiation Chemistry, Department of Chemistry, Technical University of Lodz, Zeromskiego 116, 90-924 Lodz, Poland.

ORCID-Profile: Ewelina Namiecińska, Piotr Paneth, Elzbieta Budzisz

Förderung

  • Medical University of Lodz

Zitieren

APA

Hikisz, P., Namiecińska, E., Paneth, P., & Budzisz, E. (2023). Mechanistic Studies of Arene–Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs. Molecules. https://doi.org/10.3390/molecules28093969

Vancouver

Hikisz P, Namiecińska E, Paneth P, Budzisz E. Mechanistic Studies of Arene–Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs. Molecules. 2023. doi:10.3390/molecules28093969

BibTeX
@article{Hikisz2023,
  author = {Hikisz, Paweł and Namiecińska, Ewelina and Paneth, Piotr and Budzisz, Elzbieta},
  title = {Mechanistic Studies of Arene–Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28093969}
}
Kostenlos starten →